Azenta (AZTA) Research & Development (2010 - 2026)
Azenta (AZTA) posted quarterly Research & Development of $18.6 million for Q1 2026, up 144.96% year-over-year from $7.6 million in Q1 2025, and up 102.66% quarter-over-quarter from $9.2 million in Q4 2025.
Azenta (AZTA) Research & Development (2010 - 2026) Analysis & Trends
Azenta (AZTA) has reported Research & Development for 17 consecutive years, with $18.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development rose 144.96% year-over-year to $18.6 million; the TTM figure through Mar 2026 stood at $43.5 million (up 45.72% YoY), while the FY2025 annual figure was $30.4 million, down 3.6% from the prior year.
- Research & Development advanced to $18.6 million in Q1 2026 per AZTA's latest filing, from $9.2 million in the prior quarter.
- Across five years, Research & Development topped out at $18.6 million in Q1 2026 and bottomed at $6.5 million in Q2 2022.
- Historically, Research & Development has averaged $8.4 million across 5 years, with a median of $7.6 million in 2025.
- Annual changes were most pronounced in 2024 — Research & Development dropped 15.39% — and 2026, when it soared 144.96%.
- Azenta's Research & Development stood at $7.5 million in 2022, then advanced by 5.98% to $8.0 million in 2023, then declined by 10.94% to $7.1 million in 2024, then grew by 29.19% to $9.2 million in 2025, then surged by 102.66% to $18.6 million in 2026.
- Business Quant data shows AZTA's Research & Development at $18.6 million in Q1 2026, $9.2 million in Q4 2025, and $8.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Azenta | 1.69 Bn | 1.37 Bn | 198.10 Mn | 27.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.48 Mn |
| Mar 31, 2026 | 18.62 Mn |
| Dec 31, 2025 | 9.19 Mn |
| Sep 30, 2025 | 8.26 Mn |
| Jun 30, 2025 | 7.42 Mn |
| Mar 31, 2025 | 7.60 Mn |
| Dec 31, 2024 | 7.11 Mn |
| Sep 30, 2024 | 7.54 Mn |
| Jun 30, 2024 | 7.59 Mn |
| Mar 31, 2024 | 8.41 Mn |
| Dec 31, 2023 | 7.99 Mn |
| Sep 30, 2023 | 7.12 Mn |
| Jun 30, 2023 | 8.97 Mn |
| Mar 31, 2023 | 8.52 Mn |
| Dec 31, 2022 | 7.54 Mn |
| Sep 30, 2022 | 7.65 Mn |
| Jun 30, 2022 | 6.52 Mn |
| Mar 31, 2022 | 6.90 Mn |
| Dec 31, 2021 | 6.49 Mn |
| Sep 30, 2021 | 6.60 Mn |